BioCryst launches trial to treat fibrodysplasia ossificans progressiva

Heterotopic ossification of the elbow, s/p comminuted fracture and arthroplasty. Credit: Tdvorak.



  • BioCryst launches trial to treat fibrodysplasia ossificans progressiva